Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA): Diabetes Mellitus, Type 2 trials
The registry lists 12 Diabetes Mellitus, Type 2 studies with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 4 1No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Evaluating Atherosclerotic Disease Progression in Patients With Diabetes MellitusRecruitingNCT07237685
- Effect Dietary Fructose on Fructose Kinetics in Type 2 DiabetesRecruitingNCT05717608Not applicable
- Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 DiabetesRecruitingNCT05597202Phase 4
- Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes PatientsActive, not recruitingNCT06092476Not applicable
- A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF TherapyCompletedNCT05984238Not applicable
- The Effect of Statin Treatment on Arterial Wall Inflammation as Assessed With 68Ga-DOTATATE PET-CTCompletedNCT05730634Not applicable
- Brain Clock and Insulin ResistanceCompletedNCT05314855
- QUANtification of Cardiovascular Autonomic Neuropathy (CAN) and the Effects of Anaesthesia on Haemodynamics and Cerebral PerfusionCompletedNCT03071432Not applicable
- Brown Adipose Tissue and Body Mass IndexCompletedNCT02173834Not applicable
- Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes MellitusCompletedNCT02036372Not applicable
- Web-based Insulin Titration - An Efficacy StudyCompletedNCT01715090Not applicable
- Diet, Insulin Sensitivity And the BrainCompletedNCT01297738Not applicable